제이에스링크

127120KOSDAQ자연과학 및 공학 연구개발업

51.0 / 100

Reference Date: 2026-04-13

Financial Score13.5 / 40

News Sentiment12.5 / 25

Momentum13.0 / 20

Disclosure12.0 / 15

AI Analysis: Operating Profit is on a declining trend, ROE is below the industry average. Slightly up 1.7% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

JS Link operates in genomics analysis, personalized medicine, and diagnostics, leveraging advancements in genomic technology and rising demand for customized treatments. As genome sequencing costs have drastically decreased and bioinformatics becomes crucial for handling large data, the molecular diagnostics market is rapidly expanding. Establishing Asia-specific genomic databases is key to securing global competitiveness.

Number of Employees

139people

Average Salary

53.5M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 120.074.0Point

PBR

—Industry Average 3.823.5Point

ROE

-35.13Industry Average -32.113.5Point

In line with industry avg

Debt Ratio

9.28Industry Average 7.522.0Point

Higher than industry avg (caution)

Trend 2023~20250.5 / 10 points

Revenue Growth Rate

0.5 / 3

Avg ▼3.0% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼73.4% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -32.6% (declining, 3yr)

Detailed News Sentiment

1 totalPositive 0Neutral 1Negative 0Average Sentiment Score 50

Neutral
[서울데이터랩]‘메쥬’ 199.54% 폭등…실시간 상승률 1위
메쥬, 이노인스트루먼트, 케이엠제약 등 다른 종목의 실시간 상승률을 다룬 뉴스이며, 제이에스링크와 직접적인 관련은 없습니다.

Detailed Momentum

52-week position8.0Point

Near 52w high (100%, uptrend)

Current 42,600Won52-week high 42,60052-week low 8,340

1-month return3.0Point

1m 1.67% (flat)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

14 totalPositive 1Neutral 13Negative 0

Neutral주식등의대량보유상황보고서(일반)2026-04-06
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-04-06
Neutral정기주주총회결과2026-03-31
Neutral주식매수선택권부여에관한신고2026-03-31
Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-31